# A Randomized Clinical Trail of The Effect of Postoperative Uric Acid Control on Stone Recurrence and Renal Function in Patients With Hyperuricemia of Urolithiasis.

> **NCT04398251** · PHASE4 · UNKNOWN · sponsor: **Xuhui Central Hospital, Shanghai** · enrollment: 100 (estimated)

## Conditions studied

- Hypouricemia, Renal
- Urolithiasis

## Interventions

- **DRUG:** Febuxostat 40mg Tab
- **BEHAVIORAL:** Non-drug control group

## Key facts

- **NCT ID:** NCT04398251
- **Lead sponsor:** Xuhui Central Hospital, Shanghai
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-10
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-05-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04398251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04398251, "A Randomized Clinical Trail of The Effect of Postoperative Uric Acid Control on Stone Recurrence and Renal Function in Patients With Hyperuricemia of Urolithiasis.". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT04398251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*